
CAS 1698878-14-6
:Formula:C20H25N3O5S
InChI:InChI=1S/C20H25N3O5S/c1-20(2,25)14-29(26,27)22-17-6-5-16-12-23(9-7-15(16)10-17)19(24)13-28-18-4-3-8-21-11-18/h3-6,8,10-11,22,25H,7,9,12-14H2,1-2H3
InChI key:QHHSCLARESIWBH-UHFFFAOYSA-N
SMILES:CC(C)(CS(=O)(=O)NC1=CC2=C(CN(CC2)C(=O)COC3=CN=CC=C3)C=C1)O
Filter by
Purity percentage
0
100
|
0
|
50
|
90
|
95
|
100
Found 8 products.
- Lower prices
- Higher prices
- Lower purities
- Higher purities
- Faster estimated delivery
Nampt-IN-1
CAS:2-Hydroxy-2-methyl-N-(2-(2-(pyridin-3-yloxy)acetyl)-1,2,3,4-tetrahydroisoquinolin-6-yl)propane-1-sulfonamideFormula:C20H25N3O5SPurity:99%Molecular weight:419.49Nampt-IN-1
CAS:Nampt-IN-1 (LSN3154567) (LSN3154567) is a potent and selective NAMPT inhibitor. Nampt-IN-1 inhibits purified NAMPT with an IC50 of 3.1 nM.Formula:C20H25N3O5SPurity:99.28% - 99.4%Color and Shape:SolidMolecular weight:419.49Ref: TM-T4376
1mg37.00€2mg49.00€5mg79.00€1mL*10mM (DMSO)87.00€10mg130.00€25mg245.00€50mg409.00€100mg605.00€LSN 3154567
CAS:Nicotinamide phosphoribosyl transferase (NAMPT) competitive inhibitor with IC50 = 3.1 nM. A major consequence of NAMPT inhibition is the attenuation of glycolysis at the GADPH step because this enzyme requires NAD+ for activity. The compound exhibits broad spectrum anti-cancer activity and significant tumor regression was observed in vitro. Although retinal and haematological toxicity has been associated with NAMPT inhibitors, LSN 3154567 does not lead to retinopathy in rats and can be mitigated with co-administration of nicotinic acid.Formula:C20H25N3O5SPurity:Min. 95%Color and Shape:PowderMolecular weight:419.5 g/mol







